|
Richard A. Houghten is a heterocyclic organic chemist and founder of the journal ''Peptide Research'', which was later merged with the ''International Journal of Peptide and Protein Research,'' to become the ''Journal of Peptide Research''. His work mainly concerns peptide activity and pharmacology.〔 〕 He is the founder and president of the Torrey Pines Institute for Molecular Studies (TPIMS), a biomedical research institute. Houghten pioneered the "tea-bag" approach of producing peptides for pharmacological work.〔 〕 He is author of over five hundred scientific papers, 38 of which have been cited at least one hundred times. His h-index is over 60. ==Biography== Houghten received his PhD in organic chemistry from the University of California, Berkeley in 1975. He had previously received a BS in chemistry from California State University, Fresno and an M.S. in Chemistry from Berkeley. He held a postdoctoral fellowship at the University of California, San Francisco, then an assistant professorship at Mount Sinai School of Medicine, City University of New York, and then joined the Scripps Research Institute, La Jolla, working with Richard Lerner. Houghten branched out to the business world in the 1980s, forming Multiple Peptide Systems in 1986, the Torrey Pines Institute for Molecular Studies (TPIMS) in 1988 and Houghten Pharmaceuticals, Inc. in 1990.〔 〕〔 〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Richard A. Houghten」の詳細全文を読む スポンサード リンク
|